91 related articles for article (PubMed ID: 2598499)
1. Liver-specific and high-level expression of human serum amyloid P component gene in transgenic mice.
Iwanaga T; Wakasugi S; Inomoto T; Uehira M; Ohnishi S; Nishiguchi S; Araki K; Uno M; Miyazaki J; Maeda S
Dev Genet; 1989; 10(5):365-71. PubMed ID: 2598499
[TBL] [Abstract][Full Text] [Related]
2. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation.
Zahedi K; Whitehead AS
J Immunol; 1989 Nov; 143(9):2880-6. PubMed ID: 2809211
[TBL] [Abstract][Full Text] [Related]
3. Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.
Murakami T; Yi S; Maeda S; Tashiro F; Yamamura K; Takahashi K; Shimada K; Araki S
Am J Pathol; 1992 Aug; 141(2):451-6. PubMed ID: 1497094
[TBL] [Abstract][Full Text] [Related]
4. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation.
Mortensen RF; Beisel K; Zeleznik NJ; Le PT
J Immunol; 1983 Feb; 130(2):885-9. PubMed ID: 6600258
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?
Gillmore JD; Hutchinson WL; Herbert J; Bybee A; Mitchell DA; Hasserjian RP; Yamamura K; Suzuki M; Sabin CA; Pepys MB
Immunology; 2004 Jun; 112(2):255-64. PubMed ID: 15147569
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury.
Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG
Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288
[TBL] [Abstract][Full Text] [Related]
7. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
Maeda S
Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
[TBL] [Abstract][Full Text] [Related]
8. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes.
Ochrietor JD; Harrison KA; Zahedi K; Mortensen RF
Cytokine; 2000 Jul; 12(7):888-99. PubMed ID: 10880233
[TBL] [Abstract][Full Text] [Related]
9. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice.
Szalai AJ; van Ginkel FW; Dalrymple SA; Murray R; McGhee JR; Volanakis JE
J Immunol; 1998 Jun; 160(11):5294-9. PubMed ID: 9605127
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific and developmental expression of human transthyretin gene in transgenic mice.
Yamamura K; Wakasugi S; Maeda S; Inomoto T; Iwanaga T; Uehira M; Araki K; Miyazaki J; Shimada K
Dev Genet; 1987; 8(4):195-205. PubMed ID: 3502973
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis.
Cho HY; Choi HJ; Sun HJ; Yang JY; An JH; Cho SW; Kim SW; Kim SY; Kim JE; Shin CS
Bone; 2010 Aug; 47(2):263-71. PubMed ID: 20472109
[TBL] [Abstract][Full Text] [Related]
12. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine.
Le PT; Muller MT; Mortensen RF
J Immunol; 1982 Aug; 129(2):665-72. PubMed ID: 6806378
[TBL] [Abstract][Full Text] [Related]
13. Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease.
Soma M; Tamaoki T; Kawano H; Ito S; Sakamoto M; Okada Y; Ozaki Y; Kanba S; Hamada Y; Ishihara T; Maeda S
Biochem Biophys Res Commun; 2001 Aug; 286(1):200-5. PubMed ID: 11485329
[TBL] [Abstract][Full Text] [Related]
14. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
15. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen.
Noursadeghi M; Bickerstaff MC; Gallimore JR; Herbert J; Cohen J; Pepys MB
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14584-9. PubMed ID: 11121061
[TBL] [Abstract][Full Text] [Related]
16. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
[TBL] [Abstract][Full Text] [Related]
17. Mannose binding protein is involved in first-line host defence: evidence from transgenic mice.
Tabona P; Mellor A; Summerfield JA
Immunology; 1995 May; 85(1):153-9. PubMed ID: 7635515
[TBL] [Abstract][Full Text] [Related]
18. Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
Lichtenheld MG; Podack ER; Levy RB
J Immunol; 1995 Mar; 154(5):2153-63. PubMed ID: 7868890
[TBL] [Abstract][Full Text] [Related]
19. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
[TBL] [Abstract][Full Text] [Related]
20. Isolation and analysis of murine serum amyloid P component cDNA clones.
Mole JE; Beaulieu BL; Geheran CA; Carnazza JA; Anderson JK
J Immunol; 1988 Nov; 141(10):3642-6. PubMed ID: 3183383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
